Words of wisdom. Re: Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status
Eur Urol
.
2012 May;61(5):1062-3.
doi: 10.1016/j.eururo.2012.02.011.
Authors
William M Hilton
1
,
Robert S Svatek
Affiliation
1
US Air Force, Lackland AFB, San Antonio, TX, USA.
PMID:
22469412
DOI:
10.1016/j.eururo.2012.02.011
No abstract available
Publication types
Comment